Saturday, February 4, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Clinical Research
1 of 4
Previous |
Next
Clinical Research
Indipharm: your gateway to clinical trials in India
India is fast becoming a very attractive destination for clinical trials.
No Comments
Improving Treatment for Diabetes
Dr. James Shannon of Novartis tells NGP about the advantages its new diabetes treatments will bring to patients.
No Comments
Fighting heart disease
Dr. Andrew Plump of Merck & Co., Inc. tells NGP about the groundbreaking research being carried out on the treatment and prevention of cardiovascular disease.
No Comments
Biotherapeutics: the way of the future?
Dr. Katherine Call of sanofi-aventis spoke to NGP about the growing significance of biotherapeutics for the pharmaceutical industry.
No Comments
Translational medicine paradigm: hip or hype?
Adrian Bot, Senior Director of Scientific Management and Acting Head of Translational Medicine, at MannKind Corporation explains the basics of translational medicine.
No Comments
1 of 4
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.